© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
N N-Dimethyl-L-phenylalanine didn’t appear in the chemical world by accident. This amino acid derivative has its roots tangled in the postwar era when peptide and pharmaceutical chemistry grew fast. Researchers wanted to tweak natural amino acids to produce building blocks that chemists could use to control biological activity, make medicines longer-lasting, and test hypotheses about how proteins work in the body. While most people outside the lab never see such compounds, their story winds through patent filings, journal articles, and often heated debate about the best way to stretch the boundaries of life’s basic molecules.
On the bench, N N-dimethyl-L-phenylalanine delivers a striking twist to the well-known L-phenylalanine, long famous for its role as an essential amino acid in health and food science. By adding two methyl groups to the nitrogen, chemists give the molecule properties that steer it far from the biological pathways of its simpler cousin. This small switch transforms how proteins handle the molecule and prompts researchers to use it for crafting enzyme-resistant peptides, designing novel sensors, and exploring the fine rules that govern receptor binding in drug discovery.
This molecule steps into the lab as a crystalline solid with a neutral or faintly sweet odor and a tendency to cling to glassware unless handled with care. Its additional methyl groups draw attention because they increase lipophilicity, letting the molecule pass into places water-loving amino acids can’t easily reach. At the same time, chemists have found it keeps its basic backbone sturdy under routine reaction conditions, sparing them the headaches that come from less stable analogues. You’ll find the white or off-white powder behaves as most amino acids do in routine dissolution, but watch out: solubility tips more toward organic solvents, adding a helpful trick to the mix for tricky syntheses.
N N-Dimethyl-L-phenylalanine often lands in the lab with the L-configuration and careful attention from both suppliers and regulatory bodies. Chemically pure samples warrant rigorous inspection: melting points documented, rotation angles checked under the polarimeter, and water content measured to assure consistency. In practice, the molecule packs away in light-resistant containers, sealed to avoid moisture, marked for research—not food or drug use. Labeling carries reminders of its research-grade status and the need for responsible use, as mislabeling could scramble whole experiments and lead to wasted resources.
No universal shortcut exists for making N N-dimethyl-L-phenylalanine. Most synthetic routes favor either reductive methylation or double alkylation of L-phenylalanine, relying on anhydrous conditions and vigilant monitoring to prevent byproducts. I remember colleagues laboring over methylation reactions—pausing to tweak pH, solvent mix, or reaction time—just to purify out a batch that would pass HPLC and NMR analysis. Each batch can differ in yield or purity if the team cuts corners, so skill and patience separate robust synthetic plans from those that leave the product streaked with impurities.
N N-dimethyl-L-phenylalanine handles itself boldly under coupling reactions, securely attaching to other amino acids in solid-phase peptide synthesis. Its altered amine blocks further peptide elongation from that end, which turns the molecule into a tool for constructing capped peptides or producing peptidomimetics resistant to enzyme breakdown. The aromatic side chain opens the door for aromatic substitutions, cross-coupling, and other targeted modifications, giving chemists room to tinker for both biological testing and new reactions. Over years in the lab, I watched it become a go-to choice when peptide modifications called for predictable, clean reactivity.
Depending on where you look, N N-dimethyl-L-phenylalanine answers to a variety of handles. In old-school chemistry texts, it might hide under DMPA or simply Dimethylphenylalanine. Some catalogs toss around long systematic names ending in methyl and amino suffixes, and those labels can nudge users to double-check before ordering—missteps from a simple letter swap mean hours lost in troubleshooting. Listing by CAS number helps ensure chemists land on the right entry among a sea of lookalike compounds.
Despite its close relationship with phenylalanine, N N-dimethyl-L-phenylalanine never finds its way into nutritional supplements or commercial food production. Strict lab safety routines kick in: researchers work with gloves, eye protection, and well-ventilated hoods. Spills don’t trigger alarms, but everyone cleans carefully to avoid contamination of other peptides or small-molecule stocks. Waste gets segregated, and chemical logs track how much gets used, discarded, or stored long term. The same standards that apply to handling organics and lab-scale reagents suit this compound, though its particular modifications put it outside routine toxicological evaluation or public health oversight.
In my time watching pharmaceutical science move forward, N N-dimethyl-L-phenylalanine kept showing up in lead optimization programs for peptide drugs. Chemists value its stable amine for protecting molecules against the swarms of peptidases that chew up unmodified peptides in blood plasma. Medicinal teams chase after analogues with unique properties—improved brain permeability, longer half-lives, new patterns of receptor activation. Chemical biologists grab this molecule for probing the workings of transporters and receptors, revealing hidden binding sites overlooked by natural amino acids. Beyond medicine, it crops up in material science and molecular recognition tools, where the push for precise, durable chemical motifs never ends.
A quick look through patents and research journals shows N N-dimethyl-L-phenylalanine riding the crest of both basic science and applied innovation. Universities and biotech startups turn to this amine for both custom peptide libraries and enzyme-resistant probes for protein engineering. Several research groups push the boundaries further, chiming in with novel synthesis routes that cut costs or minimize environmental waste. For years, I’ve seen it act as a quiet facilitator in programs searching for imaging agents, cancer drugs, or tools for dissecting biological pathways. The more scientists ask from peptides, the more N N-dimethyl-L-phenylalanine matters for robust, scalable synthesis and probing new chemical space.
Despite sharing a backbone with dietary phenylalanine, N N-dimethyl-L-phenylalanine stands apart from the nutrition aisle or public health screen. Toxicology studies remain sparse, since the compound only rarely gets handled outside tightly regulated labs. Most available studies cover in vitro or small-animal models, reporting low acute toxicity compared with pharmaceuticals but stopping short of extensive safety trials. The lack of routine metabolic breakdown means tissues and organs hold onto modified peptides longer—an advantage in controlled drug studies but a caution flag in undefined settings. Responsible researchers keep a close eye on handling, cross-contamination, and carefully manage any waste so it doesn't leak into the broader environment.
N N-dimethyl-L-phenylalanine’s prospects lie in the spread of precision medicine, peptide therapeutics, and chemoselective tools for biological study. As new delivery systems—like nanoparticle-carried drugs or tissue-targeted injections—grow more sophisticated, the demand for stable, modifiable amino acid derivatives keeps climbing. Chemists and biologists keep stretching the molecule’s utility, tapping into unexplored drug targets or expanding its footprint in diagnostics. Meanwhile, the green chemistry movement challenges every synthetic step, calling for lower-waste, energy-saving production. Industry and academia will have to work side by side to meet both innovation and safety challenges, making the future of N N-dimethyl-L-phenylalanine closely tied to broader trends in responsible chemical manufacturing and the quest for smarter biotechnology solutions.
Most people will never come across N N-Dimethyl-L-phenylalanine in daily life. In my time reading and writing about chemical advances, this name pops up mostly in the worlds of pharma and research. This amino acid derivative holds weight where new drugs are born and molecules are shaped to fit into the puzzle of human biology.
The appetite for more precise, targeted medicines keeps growing. Modern chemistry works hard to refine existing molecules and carve out new ones. Chemists reach for N N-Dimethyl-L-phenylalanine because it offers a tweak to the natural amino acid, phenylalanine. By swapping in two methyl groups at the nitrogen, the molecule stands out. This small shift can influence how a drug behaves in the body, helping researchers shape molecules that slip past metabolic blockers, last longer in the bloodstream, and hone in on specific targets.
For instance, I once spoke to a medicinal chemist at a conference who described how adding methyl groups can sometimes shield parts of a molecule from enzymes. That little protection means the active part of a potential medicine doesn’t get chopped up so fast. Drugmakers take advantage of anything that increases a drug’s stability and gives it a fighting chance to do its job before disappearing from the patient's system.
Breakthroughs in peptide-based drugs keep everyone on their toes. Peptides, formed from amino acids, act as messengers in the body. Designing peptide drugs sometimes comes down to swapping in a special amino acid where nature would not. N N-Dimethyl-L-phenylalanine brings something different to the table. By resisting natural breakdown, it helps make peptides last longer or bind stronger to their targets. Peptide scientists keep looking for ways to trick nature’s clean-up crews and, over the years, tailored residues like this dimethyl version give new hope for gut-stable medicines.
In many labs, especially those working on neurobiology or enzymology, N N-Dimethyl-L-phenylalanine turns up as a tool. Sometimes researchers want to see how a protein changes if a single amino acid gets replaced with this modified version. Sometimes the goal is to study how nerves signal by tweaking key building blocks for neurotransmitters. These sorts of studies uncover how the tiniest shifts in a molecule can lead to outsized changes in behavior, disease risk, or response to medications. I’ve met graduate students who spend months coaxing cells to include a single modified amino acid in a protein just to learn if it makes a difference in swelling, pain, or cell growth.
More demand for tailored medicines and smarter research tools drives up interest in molecules like N N-Dimethyl-L-phenylalanine. Making it accessible and affordable might open paths for more small drug developers and university labs. Factories have begun scaling up production, selling it not just in tiny vials but by the kilogram, making experiments possible that used to be out of reach. Building more connections between suppliers, chemists, and clinicians leads to better drugs, deeper understanding, and, ultimately, more lives improved by thinking a little differently about one simple amino acid building block.
N N-Dimethyl-L-phenylalanine shows up in chemistry texts as a derivative of the common amino acid, phenylalanine. That mouthful of a name points to two methyl groups attached to nitrogen atoms on the amino acid structure. Organizations and researchers have explored its use in pharmaceuticals, and it has potential as a building block in drug synthesis. It doesn’t show up in grocery lists or ordinary supplement stores, but questions about its safety aren’t just academic. People deserve real answers about what goes into research chemicals and their possible roles in the future of medicine or nutrition.
N N-Dimethyl-L-phenylalanine is largely restricted to laboratory research. Unlike L-phenylalanine, which shows up in common foods and approved supplements, its dimethylated cousin hasn’t earned a spot on regulatory lists in the US, EU, UK, or elsewhere as a food ingredient or additive. The US Food and Drug Administration (FDA) database contains no approvals for this compound as a food product. European agencies also do not list it as suitable for use in consumer foodstuffs or supplements. If someone spots a supplement online containing this chemical, scrutiny is justified. Unregulated chemicals pose real risks—especially for people prone to allergies, metabolic issues, or those taking prescription medication.
Peer-reviewed data offers little reassurance. Animal models provide the main source of safety information, with scattered research showing metabolic changes, but nothing conclusive for daily human consumption. A noticeable lack of published toxicity studies in mammals means no one has drawn clear lines on what counts as a safe dose for people. Genuine safety data should not hide behind paywalls or small pilot studies. For example, the Journal of Medicinal Chemistry published some articles noting pharmaceutical uses, but risk assessments in animal models sit behind closed doors. Until research turns up published results on toxicity, metabolism, and excretion in living creatures, claims about its harmlessness sound like wishful thinking.
No answers exist to basic questions: Does N N-Dimethyl-L-phenylalanine build up in tissues, or does the body clear it? Does it interact with neurotransmitters, as ordinary phenylalanine does? Can it trigger immune responses? Without these facts, people aiming to experiment with such chemicals run blindfolded into territory that well-established supplement safety rules were designed to prevent. Phenylalanine itself can worsen symptoms in people with the rare metabolic disorder PKU (phenylketonuria), so chemical cousins definitely warrant caution.
Real consumer protection starts with open publication of complete animal and human safety data. Regulatory review would strengthen transparency, help spot possible interactions, and shield the public from unexpected effects. Until those steps happen, anyone marketing, recommending, or using N N-Dimethyl-L-phenylalanine is rolling the dice. With my experience tracking questionable supplements and obscure research peptides, I tell anyone curious about these unapproved chemicals: Wait for the science. Let regulatory bodies evaluate risk before trying something that still belongs in the research pipeline, not the kitchen shelf.
N N-Dimethyl-L-phenylalanine comes up in plenty of biochemical and pharmaceutical labs, thanks to its role in making peptides or exploring new molecules. Like many amino acid derivatives, this compound is sensitive in ways that deserve consideration. Lab chemicals aren’t just powders you tuck anywhere; small details in how you store them can mean the difference between reliable experiments and wasted batches.
This compound stays in top shape at low temperatures. Cold storage—typically in a fridge set from 2°C to 8°C—makes a difference. Fluctuating temperatures can trigger gradual breakdown, and in some cases, subtle chemical changes that keep results inconsistent. Heat speeds up degradation, so keeping it out of warm rooms or next to heat vents becomes a matter of protecting your investment.
Even trace amounts of moisture can mess with N N-Dimethyl-L-phenylalanine. In my own work, forgetting to tightly seal a vial meant returning the next day to see signs of caking—surefire evidence that the material had absorbed water from the air. Some researchers use desiccators filled with silica gel, or work in low-humidity rooms, as a buffer against this issue. Keeping containers tightly capped creates an additional line of defense.
Direct sunlight or even fluorescent light can speed up chemical changes. Materials stored in amber glass bottles or protected inside opaque secondary containers last much longer. My lab always placed sensitive amino acids in dark-colored bottles, then tucked those in a metal cabinet, keeping exposure nearly zero.
Mistakes happen easily in busy spaces. Labeling every batch with the date and lot number helps track freshness. Writing the exact date when a bottle is first opened ties back to unexpected test results if anything seems off later. Keeping sensitive chemicals on a specific shelf, apart from acids or bases, cuts down the risk of harmful reactions after a spill or during cleaning.
Manufacturers usually assign expiration dates for a reason. Sticking with those guidelines preserves consistency. Polar, small molecules like N N-Dimethyl-L-phenylalanine slowly degrade with time, even in perfect storage. Checking the material before use—looking for clumps, discoloration, or strange smells—protects everyone’s work downstream. If uncertainty pops up, ordering a new batch avoids headaches later.
Using gloves and eye protection makes everyday routines safer. Direct contact increases the risk of accidental ingestion or irritation, not worth the risk for a task that only takes seconds. Most labs keep a written chemical hygiene plan and run a refresher session every year. In my experience, accidents go down—drastically—when basic training becomes a habit.
Purchasing smaller packaging sizes keeps chemicals fresher, since opening and closing the main bottle raises the chance of contamination. Electronic inventory systems help track batch turnover, so chemicals never get forgotten on the back of a crowded shelf. Improvements like these don’t just boost safety—they build the foundation for strong, reproducible research.
N N-Dimethyl-L-phenylalanine might sound like a mouthful, but at its core, we’re just talking about a modified amino acid. The chemical formula is C11H15NO2. To any trained chemist, every one of those symbols matters. Carbon and hydrogen build the backbone, nitrogen gives that unique amine group, and oxygen rounds things out with the carboxyl group. True, it only takes a minor change—a couple of methyl groups attached to the nitrogen—to go from simple phenylalanine found in your body to this synthetic tweak, and that matters more than you might think.
Anyone who has ever baked bread knows that a pinch of salt or an extra spoon of sugar can turn out completely different results. That’s how chemistry works too. Add those methyl groups to L-phenylalanine, and the compound gets new qualities. Its interaction with enzymes shifts. Pharmaceutical researchers take a keen interest in these variants because they often unlock new medical applications. In fact, many drugs and supplements have roots in common natural amino acids, altered just enough to change their behavior in the body.
L-phenylalanine is something you find in eggs, meat, and dairy. Bodies use it as a building block for proteins and neurotransmitters. The N N-dimethyl version is built in lab settings, not kitchen ones. Scientists combine L-phenylalanine with methylating agents, which stick two methyl groups onto the nitrogen. This might look simple on paper, but quality control takes skill, training, and good lab practice. Impurities in synthesis can compromise safety or effectiveness if someone’s planning to use it in drug research.
By adding methyl groups, researchers give the molecule a new set of properties. It might help control how quickly the body breaks it down, or tweak how it interacts with other molecules. Researchers in neuropharmacology study these analogues for potential in treating mental health disorders or boosting cognitive function. Pharmaceutical companies look at them for new medicine pathways. In my own college lab days, small molecular tweaks like these gave us clear lessons in just how important chemical structure is. Just a tiny shift, and a compound can switch from ordinary food ingredient to something with major health potential.
Not all chemical changes lead to safety or benefit. As new molecules like N N-dimethyl-L-phenylalanine become more common in academic and industry labs, it becomes important to keep a close eye on regulation and health assessments. Researchers and regulators need to double-check that these variants don’t produce unexpected side effects. Public understanding trails behind scientific advance, so outreach and education become just as critical as synthesis and testing. Without responsible science and transparent discussion, new compounds risk being misunderstood or misused.
In the right hands, minor changes to well-known amino acids can produce big leaps in medicine, nutrition, and biotechnology. The formula C11H15NO2 might seem small on a page, but it marks the frontier where careful research blends with imagination. Scientists, educators, and policymakers all have a role in guiding these discoveries responsibly. I’ve seen breakthroughs emerge from the tiniest tweaks to a molecule. With good research and dialogue, discoveries like N N-dimethyl-L-phenylalanine can offer real value to science and society.
N N-Dimethyl-L-phenylalanine is a mouthful, and it barely pops up in mainstream conversations. It’s a synthetic derivative of phenylalanine, an amino acid found in the food we eat—think dairy, meat, nuts, and even some artificial sweeteners. Chemists tweak natural molecules like this to create new drugs or supplements. If a novel compound gets attention in research, folks start to wonder: Is it safe enough to use, or does it bring unwanted baggage?
I learned early on to not trust untested chemicals. Food chemists usually send new candidates through a battery of animal studies, then human trials. With N N-Dimethyl-L-phenylalanine, peer-reviewed literature is thin. PubChem lists the chemical structure and little else. The Handbook of Reagents for Organic Synthesis mentions this molecule, but there’s nothing about side effects from direct human consumption—no alerts for rashes, heartburn, headaches, or other red flags that usually surface when compounds move to clinical testing.
For folks who remember the trouble with fenfluramine or certain amino acid derivatives that looked promising before issues blew up in real-world use, it’s tough to rush to trust. The lack of published evidence does not mean it’s harmless; it means no one has really put it to the test outside of the lab bottle.
There’s reason to dig into new compounds like this before anyone puts it in their diet or a supplement formulation. We’ve seen enough cases where substances that seemed safe at low doses, such as phenylalanine itself, became real issues for people with genetic disorders like PKU (phenylketonuria). In that example, the body can’t break down the amino acid, leading to serious health consequences.
N N-Dimethyl-L-phenylalanine adds another methyl group to the phenylalanine molecule, and that tiny change could impact how the body processes it—or even how it interacts with common enzymes. If you’ve followed stories on synthetic drugs or modified amino acids, you know risk often shows up in the gaps: not in the clear data, but in what hasn’t been checked. Allergic reactions, liver stress, and neurological impacts can all hide behind a lack of formal testing.
There’s another side to the story. As of 2024, the absence of clinical trials and adverse event reports for N N-Dimethyl-L-phenylalanine shows that it hasn’t entered the mainstream as a drug or supplement. That cuts both ways. Nobody has claimed side effects. Nobody has proven safety or benefit, either. In health science, silence is not the same as a green light.
I see this every week in pharmacy work. A patient has questions about some new supplement from a website they trust. If the company or researchers haven’t published animal studies, dosing data, or even product recalls, I recommend caution. Regulatory agencies such as the FDA warn against assuming safety from obscurity. They push for transparency, risk assessments, and open clinical evidence before new ingredients land in store aisles or web shops.
If the chemical ever heads for supplement shelves or drug research, researchers should publish animal toxicity tests and pilot trials first. This is how the industry builds trust and protects people from unknown harms. Companies promising new solutions based on synthetic molecules carry a responsibility: test before selling, disclose data, and don’t skip safety checkpoints, even if competition is fierce.
Until someone proves N N-Dimethyl-L-phenylalanine’s side effect profile—good or bad—the safest route stays clear of hype, focusing on ingredients with a solid history of safety and open, reliable data.
| Names | |
| Preferred IUPAC name | methyl(phenyl)amino)(2S)-2-phenylpropanoic acid |
| Other names |
(2S)-2-Amino-2-phenyl-N,N-dimethylacetamide N,N-Dimethyl-L-phenylalanine L-Phenylalanine, N,N-dimethyl- |
| Pronunciation | /ɛn ɛn daɪˈmɛθɪl ɛl fɛˌnɪl.əˈleɪ.nin/ |
| Identifiers | |
| CAS Number | 39604-56-5 |
| Beilstein Reference | 138150 |
| ChEBI | CHEBI:89885 |
| ChEMBL | CHEMBL141927 |
| ChemSpider | 61960 |
| DrugBank | DB08375 |
| ECHA InfoCard | 17a4c293-bdb8-404b-855c-5aea99c6c667 |
| EC Number | 264-866-9 |
| Gmelin Reference | 604657 |
| KEGG | C14236 |
| MeSH | D016602 |
| PubChem CID | 123524 |
| RTECS number | DO7330000 |
| UNII | 4W9F4V3N41 |
| UN number | 2811 |
| Properties | |
| Chemical formula | C11H15NO2 |
| Molar mass | 181.24 g/mol |
| Appearance | White to off-white solid |
| Odor | Odorless |
| Density | 1.06 g/cm3 |
| Solubility in water | Slightly soluble in water |
| log P | 0.10 |
| Vapor pressure | 0.0000133 mmHg at 25°C |
| Acidity (pKa) | pKa = 9.13 |
| Basicity (pKb) | 10.70 |
| Magnetic susceptibility (χ) | -73.52×10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.531 |
| Dipole moment | 3.25 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 318.5 J·mol⁻¹·K⁻¹ |
| Std enthalpy of combustion (ΔcH⦵298) | -4155 kJ mol⁻¹ |
| Pharmacology | |
| ATC code | N06BX08 |
| Hazards | |
| Main hazards | Harmful if swallowed. Causes serious eye irritation. Causes skin irritation. May cause respiratory irritation. |
| GHS labelling | GHS02, GHS07 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H302: Harmful if swallowed. |
| Precautionary statements | P261, P264, P271, P272, P273, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362+P364, P501 |
| Flash point | 130°C |
| Lethal dose or concentration | Lethal dose or concentration (LD50): Rat oral LD50 940 mg/kg |
| LD50 (median dose) | 1200 mg/kg (rat, oral) |
| NIOSH | GW2710000 |
| PEL (Permissible) | Not established |
| REL (Recommended) | 10 mg |
| Related compounds | |
| Related compounds |
Phenylalanine N,N-Dimethylphenethylamine N-Methyl-L-phenylalanine L-Phenylalanine methyl ester L-Phenylalanine ethyl ester |
